20/20 Onsite

ABOUT US

20/20 Onsite is a specialty vendor for sponsors and CROs conducting clinical trials with ocular endpoints, providing end-to-end ophthalmic trial consultation, clinical field execution, and ongoing support. Through a single-call accountability model, 20/20 Onsite helps sponsors de-risk ocular endpoint complexity and increase the likelihood of on-time, on-budget, protocol-adherent trial success.

Its proprietary point-of-need service delivery model reaches participants where they live, work, or congregate, reducing patient burden, improving retention, and supporting diverse enrollment strategies. Backed by proven expertise, nationwide experience at scale, and validated regulatory rigor, 20/20 Onsite has supported more than 45 clinical trials, served over 100,000 patients, and consistently delivered Net Promoter Scores above 95.

FEATURED ARTICLES

What Clinical Trial Management Solutions Don't Cover: The Ocular Endpoint Execution Gap

Discover how specialized endpoint execution closes critical gaps in ophthalmic trials, improving assessment consistency, protocol adherence, data quality, and participant retention.
Clinical Research Logistics: How Point-Of-Need Execution Protects Ocular Endpoints

Reduce operational risk in ophthalmic trials with point-of-need execution. Discover how mobile clinics, specialized teams, and single-call accountability protect endpoint quality and study timelines.
Ophthalmology Patient Engagement And Retention: Point-Of-Need Execution

Dropout in retinal trials is often a logistical failure. Reducing travel burden and bringing specialized care to the patient can slash attrition rates and secure critical trial timelines.
What Re-Acquisition In Retinal Imaging Is Really Costing Your Program

High screen failure rates and patient dropout often stem from preventable imaging errors. Learn how proactive quality control and patient-centric logistics secure critical retinal trial data.
When Your Protocol Includes Ocular Endpoints

Standardizing ocular endpoint execution reduces participant dropout and eliminates data variability. Specialized oversight secures clinical timelines and ensures high-quality, submission-ready data.
Ocular Hypertension In Clinical Trials: Protecting IOP Endpoints From Execution Risk

Fluctuations in eye pressure measurements can jeopardize trial results. Learn how standardized execution and equipment calibration protect data integrity and regulatory credibility.
Why Are Sponsors Prioritizing Ophthalmology Clinical Trials?

Explore how demographic shifts and retinal innovation are transforming ophthalmology trials, and why operational precision is the key to protecting data integrity in this high-growth sector.
Patient Centric Clinical Trials: Why Transportation Is A Timeline Risk

Address transportation barriers to reduce protocol deviations and data gaps. Strategies that lower travel burden protect study timelines and improve visit adherence for better trial outcomes.
How To Reduce Patient Dropout Rates In Clinical Trials

Sponsors are addressing patient dropout rates by shifting from reactive troubleshooting to proactive protocol designs that minimize participant burden.
BCVA, OCT, And IOP Testing In Clinical Trials

Are minor inconsistencies in room setup and technician technique quietly compromising your study data? Learn how closing small operational gaps can prevent major downstream risks.